Position in HLN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$10,981
-$800 QoQ
Shares Held
1,177
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#472
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Roble, Belko & Company, Inc holds $17,559 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (62.5% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,981 | 1,177 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $11,781 | 1,177 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $11,899 | 1,177 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $10,557 | 1,177 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $12,205 | 1,177 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $12,111 | 1,177 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $11,228 | 1,177 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $12,452 | 1,177 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $9,722 | 1,177 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $9,992 | 1,177 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $9,686 | 1,177 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $9,804 | 1,177 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $9,863 | 1,177 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $9,580 | 1,177 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $9,416 | 1,177 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,219 | 857 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||